CCBR is now Bioclinica.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized by three business segments to deliver focused service supporting multifaceted technologies. The Medical Imaging and Biomarkers segment provides medical imaging and cardiac safety services and includes a molecular marker laboratory. The eHealth Solutions segment comprises an eClinical technology platform and professional services along with safety and regulatory solutions. Under the Global Clinical Research segment, Bioclinica offers a global network of research sites, patient recruitment and retention services, and a post-approval research division. The Company serves more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe, Latin America and Asia.
Company Details
- Employees
- 108
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- ccbr.com
Ccbr Clinical Research (Now Bioclinica) Questions
Ccbr Clinical Research (Now Bioclinica)'s website is ccbr.com
Ccbr Clinical Research (Now Bioclinica)'s LinkedIn profile is https://www.linkedin.com/company/ccbr
Ccbr Clinical Research (Now Bioclinica) has
108 employees.
View email and phone details for 108
employees at Ccbr Clinical Research (Now Bioclinica).
Ccbr Clinical Research (Now Bioclinica)'s industry is
Pharmaceutical Manufacturing
Ccbr Clinical Research (Now Bioclinica)'s top competitors are
Qinecsa Solutions,
Apcer Life Sciences,
Iqvia,
Parexel,
Care Access Brasil,
Fortrea,
Clario,
Bioclinica,
Synarc,
Elite Safety Sciences.
Ccbr Clinical Research (Now Bioclinica)'s categories are Pharmaceutical Manufacturing
Ccbr Clinical Research (Now Bioclinica)'s founding year is 1992
